Expert Review of Pharmacoeconomics & Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research
期刊ISSN: 1473-7167
E-ISSN: 1744-8379
影响因子: 登录后查看数据
自引率: 6.7%
SCI期刊JCR分区
SCI期刊JCR分区等级:3区
按学科分区
HEALTH CARE SCIENCES & SERVICES
Q3
HEALTH POLICY & SERVICES
Q4
PHARMACOLOGY & PHARMACY
Q4
HEALTH CARE SCIENCES & SERVICES
Q3
HEALTH POLICY & SERVICES
Q4
PHARMACOLOGY & PHARMACY
Q3
《新锐期刊分区表》(2026年3月发布)
大类学科
医学
4区
小类学科
卫生保健与服务
4区
卫生政策与服务
4区
药学
4区
Top期刊
综述期刊
最新中科院SCI期刊分区(2025年3月升级版)
大类学科
医学
4区
小类学科
卫生保健与服务
4区
卫生政策与服务
4区
药学
4区
Top期刊
综述期刊
期刊简介
Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
出版信息
出版商
Taylor and Francis Ltd.
涉及的研究方向
HEALTH CARE SCIENCES & SERVICES-PHARMACOLOGY & PHARMACY
年文章数
106
出版国家或地区
ENGLAND
是否OA
Cite Score(2025年最新版)
Cite Score SJR SNIP 排名
3.8 0.585 0.662
学科
大类学科:Medicine
小类学科:Health Policy
分区
Q2
学科
大类学科:Medicine
小类学科:Pharmacology (medical)
分区
Q2
SCI期刊投稿推荐
JCR分区相关期刊
中科院分区相关期刊
去登录